Adhd

How toxic air is quietly triggering behavioural changes in children

As toxic air penetrates deep into the bloodstream and reaches the brain, experts warn of rising neuroinflammation in children that can quietly shape behaviour, learning and development

6 expert-backed ways parents can build better routines for kids with ADHD

Clear structure, calm communication, and simple, predictable habits can make daily life far smoother for families, helping children with ADHD feel secure and regulated.

No, paracetamol use in pregnancy is not linked to autism, confirms study

Debunking Donald Trump's recent claims, a new BMJ study finds no convincing evidence that taking paracetamol during pregnancy raises the risk of autism or ADHD in children

More women live with depression and anxiety than men, shows WHO data

Global data reveals that women are more prone to depression and anxiety than men, with social, biological and economic factors driving the mental health gap

ADHD medication linked to lower risk of substance abuse, crime

New research suggests stimulant treatments may protect people with ADHD from serious harms such as drug abuse, suicidal behaviour, road accidents and criminal convictions

Paracetamol use in pregnancy may lead to autism, ADHD in babies: Study

Taking paracetamol during pregnancy might increase the offspring's chances of developing neurodevelopmental disorders, including autism and attention deficit hyperactivity disorder, according to a study. Available over-the-counter, paracetamol -- also known as 'acetaminophen' -- is considered safe for managing headache, fever, and pain during pregnancy. Researchers, including those at the Icahn School of Medicine at Mount Sinai, US, analysed 46 previously published studies involving over a lakh participants across multiple countries. Findings published in the journal BioMed Central show that "higher-quality studies are more likely to show a link between prenatal acetaminophen exposure and increased risks of autism and ADHD," said author Diddier Prada, assistant professor of population health science and policy, environmental medicine and climate science, at the Icahn School of Medicine at Mount Sinai. "Given the widespread use of this medication, even a small increase in risk could

What is rejection sensitive dysphoria in ADHD and how can you manage it?

Intense emotional reactions to real or imagined rejection are part of rejection sensitive dysphoria. The term isn't a formal diagnosis, but it's gaining traction in both research and clinical work

How undiagnosed ADHD raises addiction risk, especially in women

Experts warn that undiagnosed ADHD can lead to addiction due to impulsivity, emotional dysregulation and subtle symptoms often overlooked in adult women

Glenmark recalls 1.5 million bottles of ADHD medication in US: USFDA

Glenmark Pharmaceuticals is recalling close to 15 lakh bottles of a generic medication used in the treatment of attention deficit hyperactivity disorder in the US market, according to the US health regulator. Glenmark Pharmaceuticals Inc, USA, a subsidiary of the Mumbai-based drug maker, is recalling around 14.76 lakh bottles of Atomoxetine Capsules in multiple strengths. The company is recalling the affected lot due to "CGMP Deviations", the US Food and Drug Administration (USFDA) said in its latest Enforcement Report. The recall is due to "presence of N-Nitroso Atomoxetine impurity above the FDA recommended limit," it added. New Jersey-based Glenmark Pharmaceuticals Inc, USA is recalling the made-in-India product in strengths ranging from 10 mg to 100 mg, USFDA stated. The company initiated the Class II recall on January 29 this year. As per the USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medic

Granules India gets US regulator FDA's approval for generic ADHD drug

Drug firm Granules India on Tuesday said its subsidiary has received approval from the US health regulator for a generic medication used to treat attention-deficit hyperactivity disorder. Granules Pharmaceuticals, Inc (GPI) has received approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Lisdexamfetamine Dimesylate chewable tablets, the drug firm said in a statement. The approved drug is available in multiple strengths; 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg, it added. The company's product is the generic equivalent to Takeda Pharmaceuticals' Vyvanse chewable tablets, the company said. The medication is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in adults and pediatric patients aged six years and older, as well as moderate to severe binge eating disorder (BED) in adults. Lisdexamfetamine dimesylate chewable tablets are currently published on the FDA Drug Shortages List, emphasising ..

Fahadh Faasil reveals ADHD diagnosis at 41: How does it affect adults?

Actor Fahadh Faasil said that he was clinically diagnosed with attention deficit/ hyperactivity disorder (ADHD) at the age of 41

New study challenges adult-onset of ADHD

The new study, while smaller, mined more extensive medical histories than earlier work and found that most apparent cases of adult-onset ADHD are likely the result of substance abuse or mood problems

Fast food during pregnancy could increase ADHD risk in kids

Early onset conduct problems tend to occur in tandem and can also be traced back to very similar prenatal experiences such as maternal distress or poor nutrition